Description
Continuous Glucose Monitoring (CGM) is a transformative tool in diabetes management, offering real-time insights into glucose trends and variability. During case discussions, CGM allows for a detailed review of a patient's glycemic patterns, identifying periods of hyperglycemia, hypoglycemia, and fluctuations that are often missed with traditional fingerstick testing. This data enables more precise and personalized treatment adjustments, improving both short-term control and long-term outcomes. In complex cases, CGM can guide decis Education Grant by Faes Farma Pharmaceuticals, Dubai. Join our 60-minute live online case discussion, featuring "New Approach of treatment of Diabetic Neuropathy" led by " "Dr.Ahmed Hamouda Ali Arnaout, Consultant Internal Medicine, Mediclinic Middle East Hospitals, Abu Dhabi, UAE" About the Case Discussion Topic: Emerging treatments for diabetic neuropathy focus on addressing the root causes and providing symptomatic relief. Novel therapies include advanced pain management drugs, nerve regeneration techniques, and the use of antioxidants like alpha-lipoic acid. Regenerative medicine approaches, such as stem cell therapy, aim to repair damaged nerves. Personalized treatment plans incorporating lifestyle changes, glycemic control, and physical therapy are gaining importance. These innovative strategies improve quality of life and target long-term nerve health in diabetic patients. About Assimilate by Medvarsity: Assimilate.one by Medvarsity, is dedicated to engaging with the global healthcare community. At Assimilate. one, we believe in fostering collaboration, knowledge sharing, and professional growth, all in one comprehensive platform. Assimilate.one has collection of 50,000 minutes of medical case discussions led by over 400+ renowned key opinion leaders across 30+ medical specialties. On Assimilate.one hosts live and recorded real-world medical cases that deepen your understanding and explore different approaches to patient care.
Summary Listen
- Continuous Glucose Monitoring (CGM) represents a significant advancement in diabetes management and lifestyle monitoring. While traditional finger-stick glucose testing provides a single point-in-time measurement, CGM offers a continuous view of glucose levels, tracking fluctuations throughout the day and night. The evolution from urine glucose testing in the 1920s to laboratory blood glucose checks, and eventually to portable glucose meters, has culminated in the development of CGM systems, marking a significant leap in diabetes care.
- CGM devices, attached under the skin, measure interstitial glucose levels every 1-5 minutes. This data is transmitted to a reader device, providing a continuous glucose record. This allows patients and healthcare providers to observe glucose excursions, intra-day and inter-day variability, facilitating informed decisions for blood glucose control and minimizing long-term diabetes complications.
- Indications for CGM include type 1 and type 2 diabetes, particularly for insulin-dependent individuals. It's also used in gestational diabetes to optimize insulin dosing and manage pregnancy complications. Furthermore, health-conscious individuals and those aiming for weight loss utilize CGM to understand their glucose response to food and exercise, guiding lifestyle choices.
- Various CGM devices are available, including the Freestyle Libre 2 and 3 (14-day wear), Dexcom G6 and G7 (10-day wear), and implantable CGM systems that last for extended periods. The choice of device depends on factors like cost, ease of use, and duration of sensor wear. Training is important for effective use.
- Key parameters to track with CGM include "time in range" (glucose levels between 70-180 mg/dL), with a target of at least 70% for well-controlled blood sugar. Also tracked are instances of hyperglycemia (above 180 or 250 mg/dL) and hypoglycemia (below 70 or 54 mg/dL). These metrics, along with the glucose management index, provide a comprehensive assessment of glucose control.
Sample Certificate
About the Speakers
Dr. Leena Mahana Kapoor
Specialist Internal Medicine and Diabetologist, Aster DM Healthcare, Dubai
Financial Disclosure
Comments
Comments
You must be logged in to leave a comment.